Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment
Viruses · 2023
DOI: 10.3390/v15030693 ↗Kurz gefasst
Fallbericht in der Zeitschrift Viruses, 2023. Verfasst von E Łyżwa und 8 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland. Hauptthemen laut MEDLINE: COVID-19, Lymphoma, Follicular, Organizing Pneumonia, Pneumonia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) led to a pandemic outbreak in 2019. COVID-19’s course and its treatment in immunocompromised patients are uncertain. Furthermore, there is a possibility of protracted SARS-CoV-2 infection and the need for repeated antiviral treatment. Monoclonal antibodies against CD20, which are used, among other things, in the therapy of chronic lymphocytic leukaemia and follicular lymphoma, can induct immunosuppression. We present a case report of a patient with follicular lymphoma, treated with obinutuzumab, who was diagnosed with prolonged, ongoing SARS-CoV-2 infection and related organizing pneumonia. The recognition and the treatment were challenging which makes this case noteworthy. Antiviral therapy with several medications was administrated to our patient and their temporary, positive effect was observed. Moreover, high-dose intravenous immunoglobulin was applied, because slowly decreasing IgM and IgG levels were observed. The patient also received standard treatment of organizing pneumonia. We believe that such a complex approach can create an opportunity for recovery. Physicians should be conscious of the course and treatment possibilities facing similar cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
- Department of Radiology, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
- Department of Microbiology, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
- Department of Pathology, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
ORCID-Profile: M Sobiecka, K Lewandowska
Zitieren
APA
Łyżwa, E., Sobiecka, M., Lewandowska, K., Siemion-Szcześniak, I., Barańska, I., Klatt, M., Langfort, R., Szturmowicz, M., & Tomkowski, W. (2023). Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment. Viruses. https://doi.org/10.3390/v15030693
Vancouver
Łyżwa E, Sobiecka M, Lewandowska K, Siemion-Szcześniak I, Barańska I, Klatt M, et al. Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment. Viruses. 2023. doi:10.3390/v15030693
BibTeX
@article{ywa2023,
author = {Łyżwa, E and Sobiecka, M and Lewandowska, K and Siemion-Szcześniak, I and Barańska, I and Klatt, M and Langfort, R and Szturmowicz, M and Tomkowski, W},
title = {Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15030693}
}
EUVIMED